ID CP2D6_PANPA Reviewed; 497 AA. AC Q2XNC9; DT 24-JAN-2006, integrated into UniProtKB/Swiss-Prot. DT 20-DEC-2005, sequence version 1. DT 24-JAN-2024, entry version 73. DE RecName: Full=Cytochrome P450 2D6; DE EC=1.14.14.- {ECO:0000250|UniProtKB:P10635}; DE AltName: Full=CYPIID6; DE AltName: Full=Cholesterol 25-hydroxylase {ECO:0000250|UniProtKB:P10635}; DE AltName: Full=Cytochrome P450-DB1; DE AltName: Full=Debrisoquine 4-hydroxylase; GN Name=CYP2D6; OS Pan paniscus (Pygmy chimpanzee) (Bonobo). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Pan. OX NCBI_TaxID=9597; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Koch W.H., Nikoloff D.M., Lu W., Pan R.M., deLeon J., Wedlund P.J.; RT "CYP2D6 evolution and allele diversity among human races."; RL Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of CC fatty acids, steroids and retinoids. Mechanistically, uses molecular CC oxygen inserting one oxygen atom into a substrate, and reducing the CC second into a water molecule, with two electrons provided by NADPH via CC cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the CC epoxidation of double bonds of polyunsaturated fatty acids (PUFA). CC Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to CC 20-hydroxyeicosatetraenoic acid ethanolamide (20-HETE-EA) and 8,9-, CC 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), CC potentially modulating endocannabinoid system signaling. Catalyzes the CC hydroxylation of carbon-hydrogen bonds. Metabolizes cholesterol toward CC 25-hydroxycholesterol, a physiological regulator of cellular CC cholesterol homeostasis. Catalyzes the oxidative transformations of CC all-trans retinol to all-trans retinal, a precursor for the active form CC all-trans-retinoic acid. Also involved in the oxidative metabolism of CC drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic CC antidepressants. {ECO:0000250|UniProtKB:P10635}. CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (8R,9S)-epoxy-(5Z,11Z,14Z)- CC eicosatrienoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49884, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:131975; Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49885; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (11R,12S)-epoxy-(5Z,8Z,14Z)- CC eicosatrienoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49880, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:131970; Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49881; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (14S,15R)-epoxy-(5Z,8Z,11Z)- CC eicosatrienoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49856, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:131964; Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49857; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine + O2 + reduced CC [NADPH--hemoprotein reductase] = H(+) + H2O + N-(8,9-epoxy- CC 5Z,11Z,14Z-eicosatrienoyl)-ethanolamine + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:53140, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:2700, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:136989; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53141; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine + O2 + reduced CC [NADPH--hemoprotein reductase] = H(+) + H2O + N-(11,12-epoxy- CC 5Z,8Z,14Z-eicosatrienoyl)-ethanolamine + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:53144, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:2700, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:136990; Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53145; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine + O2 + reduced CC [NADPH--hemoprotein reductase] = H(+) + H2O + N-(14,15-epoxy- CC 5Z,8Z,11Z-eicosatrienoyl)-ethanolamine + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:53148, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:2700, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:136991; Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53149; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine + O2 + reduced CC [NADPH--hemoprotein reductase] = H(+) + H2O + N-(20-hydroxy- CC 5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:53152, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:2700, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:136992; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53153; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (17S,18R)-epoxy-(5Z,8Z,11Z,14Z)- CC eicosatetraenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:39783, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:58562, CC ChEBI:CHEBI:76635; Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39784; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (19R,20S)-epoxy-(4Z,7Z,10Z,13Z,16Z)- CC docosapentaenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:52120, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:77016, CC ChEBI:CHEBI:136410; Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52121; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (19S,20R)-epoxy-(4Z,7Z,10Z,13Z,16Z)- CC docosapentaenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:52124, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:77016, CC ChEBI:CHEBI:136411; Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52125; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=cholesterol + O2 + reduced [NADPH--hemoprotein reductase] = CC 25-hydroxycholesterol + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:50256, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:16113, ChEBI:CHEBI:42977, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210; Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50257; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- CATALYTIC ACTIVITY: CC Reaction=all-trans-retinol + O2 + reduced [NADPH--hemoprotein CC reductase] = all-trans-retinal + H(+) + 2 H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:42092, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17336, CC ChEBI:CHEBI:17898, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42093; CC Evidence={ECO:0000250|UniProtKB:P10635}; CC -!- COFACTOR: CC Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250}; CC -!- PATHWAY: Cofactor metabolism; retinol metabolism. CC {ECO:0000250|UniProtKB:P10635}. CC -!- PATHWAY: Lipid metabolism; fatty acid metabolism. CC {ECO:0000250|UniProtKB:P10635}. CC -!- PATHWAY: Steroid metabolism; cholesterol metabolism. CC {ECO:0000250|UniProtKB:P10635}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:P10635}; Peripheral membrane protein CC {ECO:0000250|UniProtKB:P10635}. Microsome membrane CC {ECO:0000250|UniProtKB:P10635}; Peripheral membrane protein CC {ECO:0000250|UniProtKB:P10635}. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; DQ282163; ABB77910.1; -; Genomic_DNA. DR AlphaFoldDB; Q2XNC9; -. DR SMR; Q2XNC9; -. DR STRING; 9597.ENSPPAP00000027583; -. DR eggNOG; KOG0156; Eukaryota. DR OrthoDB; 2900138at2759; -. DR UniPathway; UPA00199; -. DR UniPathway; UPA00296; -. DR UniPathway; UPA00912; -. DR Proteomes; UP000240080; Unplaced. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell. DR GO; GO:0062188; F:anandamide 11,12 epoxidase activity; IEA:RHEA. DR GO; GO:0062189; F:anandamide 14,15 epoxidase activity; IEA:RHEA. DR GO; GO:0062187; F:anandamide 8,9 epoxidase activity; IEA:RHEA. DR GO; GO:0020037; F:heme binding; ISS:UniProtKB. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IEA:InterPro. DR GO; GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-UniPathway. DR GO; GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-UniPathway. DR GO; GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway. DR CDD; cd20663; CYP2D; 1. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR017972; Cyt_P450_CS. DR InterPro; IPR002401; Cyt_P450_E_grp-I. DR InterPro; IPR008069; Cyt_P450_E_grp-I_CYP2D-like. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR24300:SF1; CYTOCHROME P450 2D6-RELATED; 1. DR PANTHER; PTHR24300; CYTOCHROME P450 508A4-RELATED; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00463; EP450I. DR PRINTS; PR01686; EP450ICYP2D. DR PRINTS; PR00385; P450. DR SUPFAM; SSF48264; Cytochrome P450; 1. DR PROSITE; PS00086; CYTOCHROME_P450; 1. PE 3: Inferred from homology; KW Cholesterol metabolism; Endoplasmic reticulum; Fatty acid metabolism; Heme; KW Iron; Lipid metabolism; Membrane; Metal-binding; Microsome; Monooxygenase; KW Oxidoreductase; Reference proteome; Steroid metabolism; Sterol metabolism. FT CHAIN 1..497 FT /note="Cytochrome P450 2D6" FT /id="PRO_0000051732" FT BINDING 301 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 443 FT /ligand="heme" FT /ligand_id="ChEBI:CHEBI:30413" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000250" SQ SEQUENCE 497 AA; 55867 MW; B878B8B844EAD08E CRC64; MGLEALVPLA VIVTIFLLLV DLMHRRQRWA ARYPPGPLPL PGLGNLLHVD FQNTPYCFDQ LRRRFGDVFS LQLAWTPVVV LNGLAAVREA LVTHGEDTAD RPPVPITQIL GFGPRSQGVF LARYGPAWRE QRRFSVSTLR NLGLGKKSLE QWVTEEAACL CAAFANHSGR PFRPNGLLDK AVSNVIASLT CGRRFEYDDP RFLRLLDLAQ EGLKEESGFL REVLNAVPVL LHIPALAGKV LRFQKAFLTQ LDELLTEHRM TWDPAQPPRD LTEAFLAEME KAKGNPESSF NDENLRIVVA DLFSAGMVTT STTLAWGLLL MILHPDVQRR VQQEIDDVIG QVRRPEMGDQ ARMPYTTAVI HEVQRFGDIV PLGVTHMTSR DIEVQGFRIP KGTTLFTNLS SVLKDEAVWE KPFRFHPEHF LDAQGHFVKP EAFLPFSAGR RACLGEPLAR MELFLFFTSL LQHFSFSVPT GQPRPSHHGV FAFLVTPSPY ELCAVPR //